Home/Filings/4/0001583742-14-000001
4//SEC Filing

ELITE PHARMACEUTICALS INC /NV/ 4

Accession 0001583742-14-000001

$ELTPCIK 0001053369operating

Filed

Sep 28, 8:00 PM ET

Accepted

Sep 29, 5:32 PM ET

Size

6.7 KB

Accession

0001583742-14-000001

Insider Transaction Report

Form 4
Period: 2014-09-25
Hakim Nasrat A
DirectorPresident & CEO
Transactions
  • Purchase

    Common Stock

    2014-09-25$0.31/sh+434,500$133,9562,434,500 total(indirect: By IRA)
  • Purchase

    Common Stock

    2014-09-26$0.31/sh+265,500$82,3852,700,000 total(indirect: By IRA)
Holdings
  • Common Stock

    11,714,141

Issuer

ELITE PHARMACEUTICALS INC /NV/

CIK 0001053369

Entity typeoperating
IncorporatedNJ

Related Parties

1
  • filerCIK 0001053369

Filing Metadata

Form type
4
Filed
Sep 28, 8:00 PM ET
Accepted
Sep 29, 5:32 PM ET
Size
6.7 KB